The most awaited Nobel season is here. The noble committees will get together in Stockholm and Oslo and announce the prizes in Physiology or Medicine, Physics, Chemistry, Literature, Peace, and Economics.
The announcement series will be initiated with Physiology or Medicine on October 2nd at the Karolinska Institutet in Solna, Sweden.
News
M S. Swaminathan or Monkombu Sambasivan Swaminathan also known as the father of the Indian Green Revolution passed away at the of 98. He was a renowned agriculture scientist who made strategies for the Green Revolution in India.
Google is on their way to developing an ARM-Augmented Reality Microscope in a joint venture with the U.S. Department of Defense. Currently, Google has developed a prototype. They incorporate AI with the microscope system to classify cancer cells using visual indicators.
Moderna’s new mRNA (messenger Ribonucleic Acid) flu shot completed the phase 3 trials with succeeding data. They are aiming to launch in early 2024. The flu vaccine – mRNA-1010 has produced an immune response against all four A and B strains – A/H1N1, A/H3N2, influenza B/Yamagata, and B/Victoria.
Ian Wilmut, the lead for the team to create the world’s first cloned animal, Dolly the sheep, dies at the age of 79. His work at the Roslin Insitute, Edinburgh, laid the foundation for stem cell research.
The UK announced its decision to associate with Horizon Europe and Copernicus programmes through a new agreement with the European Union (EU).
Bayer confirms the positive results of their Parkinson’s stem cell therapy initial trial developed by their subsidiary BlueRock Therapeutics. The trial was conducted on 12 patients which shows signs of reducing the Parkinson’s disease symptoms. Earlier, Bayer announced the success of the trial but the details were withheld. “Bayer AG […]
The new variant of COVID-19 was initially found in Denmark on July 24 in a patient with severe symptoms and gradually found in other symptomatic patients during sample testing and screening.
The United States FDA grants accelerated approval for Pfizer’s therapy for the treatment of blood cancer (type)-affected patients which is difficult to treat.
The first oral drug suggested to treat postpartum depression (PPD) in adults, Zurzuvae (zuranolone), has received approval from the U.S. Food and Drug Administration. PPD is a significant depressive episode that can start later in pregnancy but usually starts after delivery. Until recently, the only form of therapy for PPD […]
